Richard G. Ghalie's most recent trade in MEI Pharma Inc was a trade of 560,000 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on July 5, 2022.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| MEI Pharma Inc | Richard G. Ghalie | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jul 2022 | 560,000 | 560,000 | - | - | Stock Option (Right to Buy) | |
| MEI Pharma Inc | Richard G. Ghalie | Chief Medical Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.54 per share. | 05 Jul 2022 | 8,196 | 28,927 (0%) | 0% | 0.5 | 4,426 | Common Stock |
| MEI Pharma Inc | Richard G. Ghalie | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2021 | 320,000 | 320,000 | - | - | Stock Option (Right to Buy) | |
| MEI Pharma Inc | Richard G. Ghalie | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 May 2021 | 75,000 | 75,000 | - | - | Stock Option (Right to Buy) |